For 34 years, we have been collaborating with global pharma and biotech partners to bring innovative therapies to patients in Central and Eastern Europe. Despite the region's challenging healthcare systems and complex yet promising markets, our team of 400 employees harnesses its expertise to ensure health equity in these underserved markets.

Medis is a member of the World Orphan Drug Alliance (WODA) – a global alliance of full-service regional distributors for orphan and debilitating disease products. WODA covers 152 countries in the following regions: Central and Eastern Europe, Greater China, Israel, Greece, Malta, Cyprus, Latin America, the Middle East, North Africa & Turkey, Switzerland, Australia, New Zealand and South East Asia. 

Out-licensing:
Become our commercialization partner and benefit from advanced, ready-to-launch consumer health products, which are already marketed in 20 countries and are further expanding. 
More information: www.medis.com/en/international-business/ 

Our business areas:
•	Therapeutics 
•	Hospital Care 
•	Consumer Health 
•	Aesthetics 

Our value to partners:
•	Direct local presence in 18 CEE countries 
•	Full commercialization 
•	Single point of contact and delivery 
•	Strategic and localized market access approach 
•	Highest compliance standards 
•	Financial and credit excellence 

Major Partners:
• Therapeutics: Bial – Biogen – Besins – HRA Pharma – Mundipharma – Pierre Fabre – Santen – UCB 
• Hospital Care: Abbott – Aesculap – Asahi Medical – Biotest – B. Braun – Cytosorbents – Paion 
• Consumer Health: Pleuran – Ricerpharma – Karo Healthcare – Merz – Pohl Boskamp – UP – URGO 
• Aesthetics: Merz Aesthetics – Crown Aesthetics 

• Out-licensing partners: Ferrer – Pharmalink – Sarantis – Stada

Pharmaceutical

Therapeutics

Medis

Maja Strnad Cestar

Cvetka Hočevar

Martina Perharič

Tina Vojnovic

Kristina Jeric

Alja Plevnik Kapun

Maja Rojsek

Slavko Pušavec

Erna Slana

Brigita Starešinič

Maja Frelih Pharmd

The International Business and Market Access team at Medis focuses on forging global partnerships and optimizing market strategies to bring innovative therapies to patients across Central and Eastern Europe. This team manages international collaborations, ensures seamless market entry, and tailors commercialization strategies to navigate the complex healthcare systems within these regions. By leveraging a strategic, localized approach and maintaining the highest compliance standards, the team supports Medis' mission to achieve health equity in underserved markets.

International Business and Market Access

Sales and Account Management

Marketing and Project Management

International Business and Market Access

About

Team members

Other teams at Medis

Sales and Account Management

Marketing and Project Management